AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Beta Bionics partners with Senseonics to integrate iLet Bionic Pancreas with Eversense 365 CGM system for a 2026 launch.
Sep 25, 2026
Contract Type
partnership
ConcordBiotechnologyHealthcare
Description
Beta Bionics has announced a partnership with Senseonics to connect the iLet Bionic Pancreas with the Eversense 365 CGM system. This collaboration aims to create a setup that enhances insulin delivery and is expected to launch commercially in 2026, pending regulatory approval.
Company Information
Company
Beta Bionics
Location
300 Baker Avenue, Suite 301
Concord, Massachusetts, United States
About
Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared autonomous insulin delivery device in the market and offers the potential to substantially improve overall outcomes across broad populations of PWDs.
ConcordBiotechnologyHealthcare